Volume 2 Supplement B April 2007

Cardiovascular cell therapy: lost in translation? Moving from autologous to allogeneic therapy

• Hill J

EuroIntervention Supplements (2007) 2 (Supplement B) B5-B7

Trafficking of stem/progenitor cells after myocardial injury

• Wojakowski W,
• Kucia M,
• Korzeniowska B,
• Ratajczak M,
• Tendera M

EuroIntervention Supplements (2007) 2 (Supplement B) B9-B15

Bone marrow mesenchymal stem cells and cardiac regeneration

• Bartunek J,
• Hill J,
• Behfar A,
• Wijns W,
• Vanderheyden M,
• Willemsen P,
• de Lavareille A,
• Faber B,
• Heyndrickx G,
• Terzic A

EuroIntervention Supplements (2007) 2 (Supplement B) B16-B21

Umbilical cord blood derived stem cells

• Moelker A,
• Wever K,
• Cornelissen J,
• Duncker D,
• van der Giessen WJ

EuroIntervention 2007;2:B22-B25

Adipose derived stem cells: new kids on the block

• Meliga E,
• Duckers H,
• van Geuns R-J,
• Regar E,
• de Jaegere P,
• van der Giessen WJ,
• Serruys PW

EuroIntervention Supplements (2007) 2 (Supplement B) B26-B32

Percutaneous cell delivery techniques: devices and issues

• Sherman W,
• Martens T,
• Ketner W,
• Siminiak T

EuroIntervention Supplements (2007) 2 (Supplement B) B33-B41

Magnetically supported procedures and cardiac regeneration

• Patterson M,
• Duckers E,
• Ramcharitar S,
• Meliga E,
• van Weenen S,
• Maugenest A-M,
• Perin E,
• Serruys PW

EuroIntervention Supplements (2007) 2 (Supplement B) B42-B46

The role of magnetic resonance imaging in tracking cardiac stem cell transplantation

• Graham J,
• Hill J,
• Dick A

EuroIntervention Supplements (2007) 2 (Supplement B) B47-B54

What would convince us – From bench to bedside and back

• Villa A,
• Sánchez P,
• Sanz R,
• Domínguez M,
• Fernández-Avilés F

EuroIntervention Supplements (2007) 2 (Supplement B) B55-B59

How to predict recovery after cell therapy in post-MI patients?

• Lipiecki J,
• Durel N,
• Siminiak T,
• Ponsonnaille J

EuroIntervention Supplements (2007) 2 (Supplement B) B60-B65

Persistent angina in "no option" patients with advanced coronary artery disease

• Fuchs S,
• Battler A,
• Kornowski R

EuroIntervention Supplements (2007) 2 (Supplement B) B66-B70

Clinical experience with autologous myoblast transplantation

• Meliga E,
• Duckers H,
• Spencer R,
• Kalmucki P,
• Serruys PW,
• Siminiak T

EuroIntervention Supplements (2007) 2 (Supplement B) B71-B78

Intracoronary administration of cells derived from bone marrow in acute myocardial infarction. Ready for clinical use? Lessons from the ASTAMI trial

• Lunde K,
• Aakhus S,
• Solheim S,
• Arnesen H,
• Egeland T,
• Forfang K

EuroIntervention Supplements (2007) 2 (Supplement B) B79-B83

Rationale and interim analysis data from the SEISMIC study

• Meliga E,
• Duckers H,
• Spencer R,
• Serruys PW

EuroIntervention Supplements (2007) 2 (Supplement B) B84-B88

Future trends: cell engineering for cardiac repair

• Fiszer D,
• Seidel M,
• Siminiak T,
• Kurpisz M

EuroIntervention Supplements (2007) 2 (Supplement B) B89-B94

Framework towards optimisation of bone marrow stem cells therapy for cardiac repair

• Vanderheyden M,
• Heyndrickx G,
• Wijns W,
• Bartunek J

EuroIntervention Supplements (2007) 2 (Supplement B) B95-B98